2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Ophthalmia, Sympathetic: new trials by email Literature Review of Ophthalmia, Sympathetic trials Research Report on Ophthalmia, Sympathetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Safety and Efficacy of AIN457 in Noninfectious Uveitis AIN457, AIN 457 - Non-infectious Uveitis | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2008-06-01 | 2017-07-17 |
Panuveitis (2) · Uveitis (2) · Uveitis, Intermediate (2) · Uveitis, Posterior (2) · Behcet Syndrome (1) · Birdshot Chorioretinopathy (1) · Choroidal Effusions (1) · Giant Cell Arteritis (1) · Inflammation (1) · Multifocal Choroiditis (1) · Retinal Vasculitis (1) · Sarcoidosis (1)
Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Choroid Diseases (2) · Eye Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Uveal Diseases (2) · Vascular Diseases (2) · Vasculitis (2) · Arteritis (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Adrenal Cortex Hormones (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · secukinumab (1)
Clearside Biomedical, Inc. (1) · Novartis Pharmaceuticals (1)
United States (2) · Germany (1)